Orbimed Advisors Llc - Jun 30, 2025 SCHEDULE 13G/A Report for Avalo Therapeutics, Inc. Common Stock, par value $0.001 per share (AVTX)

Filing Manager
Orbimed Advisors Llc
Reporting Manager
OrbiMed Advisors LLC
Security
Avalo Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol
AVTX
Shares outstanding
10.9M shares
Disclosed Ownership
967K shares
Ownership
8.9%
Form type
SCHEDULE 13G/A
Date filed
8/14/2025, 06:00 PM
Date of event
Jun 30, 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
OrbiMed Advisors LLC 8.9% 967K 0 967K /s/ Carl L. Gordon Carl L. Gordon / Member of OrbiMed Advisors LLC
OrbiMed Capital GP IX LLC 6% 645K 0 645K /s/ Carl L. Gordon Carl L. Gordon / Member